πŸ‡ΊπŸ‡Έ FDA
Patent

US 9562002

STAT3 inhibitor

granted A61KA61K31/166A61K31/167

Quick answer

US patent 9562002 (STAT3 inhibitor) held by The Board of Regents of the University of Texas System expires Mon Feb 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Feb 07 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K31/166, A61K31/167, A61K31/18, A61K31/222